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Abstract
Prospective medical decision-making through the use of advanced
directives is encouraged and frequently helpful in guiding treatment
for the critically ill. It is important to recognize the attendant
shortcomings when using such tools in clinical practice.
In this issue of Critical Care, Tillyard [1] explores whether
advanced directives are effective at guiding treatment
decisions for incapacitated patients. Tillyard concludes that
although advanced directives should ideally improve decision-
making, this frequently does not translate effectively at the
bedside.
Studies have shown that, in themselves, advanced directives
are insufficient to withstand the complexities of end-of-life
care [2,3]. To resolve this divide between theory and
practice, however, it is helpful to refocus the issue. We ought
not to be overly concerned with the execution and application
of advanced directives but with the motivation behind them
and the dialogue they engender over time [4].
In the United States, advanced directives are used as a
blanket term that can refer either to a living will or a durable
power of attorney, two distinct methods designed to
safeguard autonomous choice. A living will is a written
document that expresses a preference for or against specific
types of treatment; it typically becomes effective only when
the patient is incompetent and either terminally ill or
permanently unconscious. A durable power of attorney is a
document that empowers an individual surrogate (appointed
by the patient) to assume decision-making authority as soon
as the patient loses decisional capacity.
Used independently of durable powers of attorney, living wills
are seldom helpful, for a number of reasons. Unless
individuals have already been diagnosed with a particular
illness and been informed of the prognosis, it is difficult for
them to predict what their future holds; that is, what kind of
illness/injury they will suffer and what types of medical
interventions they must consider [5]. Because medicine is not
static, making a prospective determination regarding the
types of treatment one would want in the future is difficult.
The quality of life that patients may find intolerable while
healthy is apt to change when options are limited between
choosing a compromised life or choosing death; thus, the
psychological transition that an individual will undergo when
faced with such choices is heavily nuanced and cannot be
accurately predicted in advance [6]. Further, living wills tend
to be inflexible in that they express a preference but do not
offer any supporting rationale, thus leaving little room for
interpretation or authentic knowledge of the individual.
The bioethics literature suggests that it is best to combine a
living will with a durable power of attorney to ensure a
comprehensive approach to future decision-making. In this
regard an informed surrogate can adjust to changing
circumstances and maintain a collaborative relationship with
the health care team while promoting the patient’s particular
value system and respecting the individual’s autonomy.
Despite the fact that the United States is known for
supporting an assertive vision of autonomy and has
witnessed the importance of advanced decision-making
played out in the media (for example the Schiavo case), a
relatively small percentage of Americans complete advanced
directives, as Tillyard notes. The reasons for this may be
multifactorial, ranging from the demands of managed care in
which the doctor–patient relationship has been undercut by
the consumer-driven market, to the fact that in the United
States there is disparate access to health care: one-quarter
of the population is uninsured or underinsured. Other reasons
for individuals not availing themselves of the opportunity to
complete or even discuss advanced directives may include
fear, ignorance or a false sense of security that their family will
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make the best decision. This is perhaps the most dangerous
presumption because data indicate that family members
rarely make decisions that the patient would make if
competent, and the potential for conflict and guilt among
family members is great [7].
Notwithstanding their limitations, however, advanced
directives are invaluable tools that should be encouraged, not
as ends, but as a means to further communication between
patient, physician and family. Creating a living will and/or
choosing a surrogate through a durable power of attorney
should not be an isolated event broached during a time of
acute crisis but should be part of an ongoing discussion
intrinsic to the doctor–patient relationship. Establishing why
rather than whether the patient accepts or rejects treatments
gives insight into the individual’s world view and best
safeguards autonomous choice.
Competing interests
The author declares that they have no competing interests.
References
1. Tillyard ARJ: Ethics review: ‘Living wills’ and intensive care – an
overview of the American experience. Crit Care 2007, 11:219.
2. Teno J, Lynn J, Wenger N, Phillips RS, Murphy DP, Connors AF Jr,
Desbians N, Filkerson W, Bellamy P, Jnaus WA: Advance direc-
tives for seriously ill hospitalized patients: effectiveness with
the patient self-determination act and the SUPPORT interven-
tion. SUPPORT Investigators. Study to Understand Prognoses
and Preferences for Outcomes and Risks of Treatment. J Am
Geriatr Soc 1997, 45:500-507.
3. Hanson LC, Tulsky JA, Danis M: Can clinical interventions
change care at the end of life? Ann Intern Med 1997, 126:381-
388.
4. Fagerlin A, Schneider CE: Enough: the failure of the living will.
Hastings Center Report 2004, 34:30-42.
5. Kelly DF: Critical Care Ethics: Treatment Decisions in American
Hospitals. Kansas City: Sheed & Ward 1991.
6. Bishop M: Quality of life and psychosocial adaptation to
chronic illness and acquired disability: a conceptual and theo-
retical synthesis. J Rehabil 2005 [http://goliath.ecnext.com/
coms2/summary_0199-4389533_ITM
7. Hines SC, Glover JJ, Holley JC, Babrow AS, Badzek LA, Moss
AH: Dialysis patients’ preferences for family-based advance
care planning. Ann Intern Med 2000, 133:825-828.